Main Text {#sec1}
=========

There is too much we don\'t know in the midst of this pandemic. Every day we learn more about the virus and its spread, detection and infection rates, and strategies to manage COVID-19 disease. But there is still so much we don\'t know. Scientists are working around the clock to change that.

One thing we do know is that science has been badly disrupted. Labs are closed, in the reasonable hope that this will save the lives of others. Thousands of scientists are now working from home while remaking the courses they teach, tending to family members, worrying about loved ones. We know that things have gotten a lot harder.

We at *Cell Reports* are also working from home, juggling now-overlapping responsibilities, tending to family, worrying about others. But there are some things we can do to help, and this is no time for \"business as usual.\"

There are two key changes at *Cell Reports* that are related to the pandemic and that we have instituted in the last several weeks. One relates to the idea of \"scooping,\" and the other to having flexibility for revisions during the pandemic if authors cannot generate new data requested by reviewers until their labs reopen.

About \"Scooping\" {#sec1.1}
------------------

First, let's define terms. Our website states that "the primary criterion for publication in *Cell Reports*, as for all Cell Press journals, is new biological insight." The question for editors is how to define "new." Our working definition is "an advance in knowledge over the existing literature." We judge this on a case-by-case basis, depending on the field and many other factors. Externally, it's a common assumption that once a finding has been published, it immediately ceases to be "new," meaning that we might not be interested in similar work received immediately afterwards; this race to publish first and exclude other works from being published is what is commonly referred to as "scooping."

At *Cell Reports*, we reject the concept of scooping if the similar paper we receive contains findings related to recently published work and when it could reasonably be deduced that the timing of the findings overlapped. This is not a new policy, but we are making it permanent and explicit. What do we mean by "overlapping?" We consider two or more papers to be overlapping if we know or can reasonably assume that the research itself overlapped and if the first paper was recent enough that it couldn\'t have been the basis of the second paper\'s conception. It's a judgment call in practice, but the 6-month window used by our colleagues at PLoS (Kiermer and Heber, 2020; see [Web Resources](#app1){ref-type="sec"}) is a good start.

Our policy, then, is this: our judgment of conceptual advance over previous work, which is our major editorial criterion at *Cell Reports*, accounts for work that is overlapping. To us, a paper submitted today has not been scooped by a very similar paper published 6 months ago because it is reasonable to assume that the work was occurring in parallel. It's important to note that in many cases, papers drawing similar conclusions can be distinguished from each other in other ways -- approach, model system, level of mechanistic detail -- and all of these factor into our evaluation of advance. It's rare that timing would be the major issue we would consider when deciding our interest in a paper. The principle is what matters to us: scooping, which implies winners in a race, is not something we acknowledge.

How this Relates to Editorial Flexibility in a Time of Pandemic {#sec1.2}
---------------------------------------------------------------

The above is general *Cell Reports* policy; now, here are the changes. The first principle we are applying during the pandemic is related to scooping -- when a lab has been shut down, the 6-month clock stops ticking because the pandemic could have interrupted work that was in progress and that overlaps with recently published work elsewhere. Again, this will vary case-by-case, and we encourage authors to contact their handling editor if there are specific concerns, but our overall goal is to remove "worry about the fate of our *Cell Reports* submission" from authors' to-do lists.

Then there is the question of whether and when editorial decision-making at *Cell Reports* is different during the pandemic. It is. Our expectation for publication in *Cell Reports* is that the data are technically sound and properly interpreted, regardless of circumstance. Having said that, we know that many labs cannot perform the full scope of experiments they otherwise would have, and we will work with authors and reviewers to formulate a plan that benefits everyone.

When reviews come back indicating the need for revisions, we have three tools we can use:

1\. If revisions are critical for the paper to be published at *Cell Reports*, the authors get as much time as they need, with the "scoop clock" stopped.

2\. If revisions are important but not critical (a judgment we will make, often in consultation with reviewers), we will require use of a specific Discussion section, "Limitations," that explains not just limitations but specific unanswered questions that were tabled due to lab closure.

3\. We will redouble our ongoing efforts to ensure that suggested revisions are central to the paper's scope and argument. This is not a pandemic-specific goal, but it is all the more important given that peer review and revision have become even more complicated.

In summary, we never believed in scooping, but now is the time to make that explicit. We always believed in rigorous peer review and in collaborative decision-making, but we have also always valued flexibility. Now is not the time for carelessness, but it is also not the time for \"business as usual.\" It is most certainly the time to stand behind scientists.
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=============

Kiermer L. and Heber J. \"The importance of being second -- PLOS-wide edition.\" <https://blogs.plos.org/plos/2020/04/the-importance-of-being-second-plos-wide-edition/>
